Skip to content

Transcranial Magnetic Stimulation (TMS) for CRPS

Transcranial Magnetic Stimulation for CRPS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02067273
Enrollment
20
Registered
2014-02-20
Start date
2014-02-28
Completion date
2015-03-31
Last updated
2017-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex Regional Pain Syndrome (CRPS)

Brief summary

The purpose of this pilot study is to test the durability of response to Transcranial Magnetic Stimulation (TMS) for the symptoms of Complex Regional Pain Syndrome (CRPS). The investigators will test various methods of TMS for varying lengths of time in a pilot study to investigate what the clinical impact.

Interventions

DEVICETranscranial Magnetic Stimulation (TMS)

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 or older * Diagnosis of CRPS (complex regional pain syndrome) * Average pain level reported on Numerical Rating Scale meets entry criteria * Ability to perform the experimental task and procedures.

Exclusion criteria

* MRI contraindication (metal implants or devices, claustrophobia) * TMS Contraindication (eg metal implant or devices near the site of stimulation) * History of epilepsy * History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher. * Neurologic illness that would interfere with brain integrity * Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher. * Currently pregnant or planning to become pregnant. * On going legal action or disability claim.

Design outcomes

Primary

MeasureTime frameDescription
Present Pain IntensityBaseline, post-treatment, one week follow-upPresent pain intensity was reported by participants using a visual analog scale (VAS) from scores ranging from 1-10; lower scores represent less pain, higher scores represent more severe pain.

Countries

United States

Participant flow

Participants by arm

ArmCount
TMS Intervention for 1 Day
Application of Transcranial Magnetic Stimulation (TMS) for 1 day Transcranial Magnetic Stimulation (TMS)
5
TMS Intervention for 5 Days
Application of Transcranial Magnetic Stimulation (TMS) once a day for 5 days Transcranial Magnetic Stimulation (TMS)
12
Total17

Baseline characteristics

CharacteristicTMS Intervention for 5 DaysTMS Intervention for 1 DayTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants1 Participants2 Participants
Age, Categorical
Between 18 and 65 years
11 Participants4 Participants15 Participants
Age, Continuous42.92 years
STANDARD_DEVIATION 13.69
49.8 years
STANDARD_DEVIATION 16.47
44.94 years
STANDARD_DEVIATION 14.39
Region of Enrollment
United States
12 participants5 participants17 participants
Sex: Female, Male
Female
12 Participants4 Participants16 Participants
Sex: Female, Male
Male
0 Participants1 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 50 / 15
other
Total, other adverse events
1 / 510 / 15
serious
Total, serious adverse events
0 / 50 / 15

Outcome results

Primary

Present Pain Intensity

Present pain intensity was reported by participants using a visual analog scale (VAS) from scores ranging from 1-10; lower scores represent less pain, higher scores represent more severe pain.

Time frame: Baseline, post-treatment, one week follow-up

Population: Data from participants who completed the study were analyzed.

ArmMeasureGroupValue (MEAN)Dispersion
TMS Intervention (1 Day)Present Pain IntensityBaseline6.5 Units on a scaleStandard Deviation 2.3
TMS Intervention (1 Day)Present Pain IntensityPost-treatment3.1 Units on a scaleStandard Deviation 3.1
TMS Intervention (1 Day)Present Pain IntensityOne week follow-up4.6 Units on a scaleStandard Deviation 4
TMS Intervention (5 Days)Present Pain IntensityBaseline6.3 Units on a scaleStandard Deviation 1.4
TMS Intervention (5 Days)Present Pain IntensityPost-treatment3.7 Units on a scaleStandard Deviation 3
TMS Intervention (5 Days)Present Pain IntensityOne week follow-up4.3 Units on a scaleStandard Deviation 2.7

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026